To join this virtual session, please utilize the following link:
https://us02web.zoom.us/j/81526736236
Neuromuscular disease specialists, general neurologists, their expanded care teams, and other healthcare providers who contribute to the management of patients with gMG
In support of improving patient care, AcademicCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
AcademicCME designates this live material for a maximum of 1.0 AMA PRA Category 1 CreditTM.
Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Supported by an independent educational grant from Vor Biopharma.
Virtual Session
For all CE inquiries or special needs, please contact admin@academiccme.com.
Review the current therapeutic landscape for the disease-modifying treatment of patients with gMG and identify unmet patient needs
Discuss the mode of action and current clinical trial data for dual fusion protein treatments for patients with gMG
Develop strategies for developing individualized treatment plans to manage patients with AChR-Ab or MuSK-Ab positive gMG, including the potential role of BAFF/APRIL inhibitors
To join this virtual session, please utilize the following link:
https://us02web.zoom.us/j/81526736236